Exposure to hepatitis B virus: guidance on post-exposure prophylaxis. PHLS Hepatitis Subcommittee.
This paper summarises the views of the PHLS Hepatitis Subcommittee on prophylaxis after exposure to known and potential sources of hepatitis B virus (HBV) at work and in the community, and expands on the guidance on hepatitis B immunisation and the prevention of occupational exposure to blood given elsewhere. It defines significant exposure and gives guidance on incident recording, risk assessment, testing and storage of incident-related blood specimens and follow-up. It recommends that HBV prophylaxis should be determined by assessment of the likely infectivity of the source and of the HBV status of the person exposed.
D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D006509:Hepatitis B / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D017325:Hepatitis B Vaccines; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D016273:Occupational Exposure; D012307:Risk Factors; D012308:Risk Management
D017325:Hepatitis B Vaccines; D016756:Immunoglobulins, Intravenous